APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stem Cells

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

Selected research

Market Outlook & Growth Opportunities

Global Stem Cells Market Outlook and Growth Opportunities 2026

1 January 2026201 pages

Choose your research edition.

Industry ResearchStem Cells Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Stem Cells Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Stem Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stem Cells Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Stem Cells Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.

This report provides an overview of the global Stem Cells market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Stem Cells and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Stem Cells revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Stem Cells market.

Stem Cells Segment by Company

Osiris Therapeutics

NuVasive

Chiesi Pharmaceuticals

Medi-post

JCR Pharmaceutical

MolMed

Pharmicell

Anterogen

Takeda (TiGenix)

CBR

ViaCord

Esperite

LifeCell

CCBC

VCANBIO

BOYA LIFE

Beike Biotechnology

International Medical

Stem Cells Segment by Type

Stem Cell Storage

Stem Cell Pharmaceutical and Treatment

Stem Cells Segment by Application

Diseases of the Central Nervous System

Cardiovascular Disease

Diabetes

Cancer

Genetic Diseases

Autoimmune Disease

Bone and Cartilage Repair

Other

Stem Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Stem Cells status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Stem Cells key companies, revenue, market share, and recent developments.

3. To split the Stem Cells breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Stem Cells market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Stem Cells significant trends, drivers, influence factors in global and regions.

6. To analyze Stem Cells competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Stem Cells industry.

Chapter 3: Detailed analysis of Stem Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Stem Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Stem Cells in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Stem Cells Industry Trends Table 2. Stem Cells Industry Drivers Table 3. Stem Cells Industry Opportunities and Challenges Table 4. Stem Cells Industry Restraints Table 5. Global Stem Cells Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Stem Cells Revenue Share by Company (2021-2026) Table 7. Global Stem Cells Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Stem Cells Key Company Manufacturing Base & Headquarters Table 9. Global Stem Cells Company, Product Type & Application Table 10. Global Stem Cells Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Stem Cell Storage Table 15. Significant Companies of Stem Cell Pharmaceutical and Treatment Table 16. Global Stem Cells Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Stem Cells Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Stem Cells Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Stem Cells Sales Value Share by Type (2021-2026) Table 20. Global Stem Cells Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Diseases of the Central Nervous System Table 22. Significant Companies of Cardiovascular Disease Table 23. Significant Companies of Diabetes Table 24. Significant Companies of Cancer Table 25. Significant Companies of Genetic Diseases Table 26. Significant Companies of Autoimmune Disease Table 27. Significant Companies of Bone and Cartilage Repair Table 28. Significant Companies of Other Table 29. Global Stem Cells Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Stem Cells Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Stem Cells Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Stem Cells Sales Value Share by Application (2021-2026) Table 33. Global Stem Cells Sales Value Share by Application (2027-2032) Table 34. Global Stem Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Stem Cells Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Stem Cells Sales Value Share by Region (2021-2026) Table 37. Global Stem Cells Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Stem Cells Sales Value Share by Region (2027-2032) Table 39. Global Stem Cells Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Stem Cells Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Stem Cells Sales Value Market Share by Country (2021-2026) Table 42. Global Stem Cells Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Stem Cells Sales Value Market Share by Country (2027-2032) Table 44. Osiris Therapeutics Company Information Table 45. Osiris Therapeutics Business Overview Table 46. Osiris Therapeutics Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Osiris Therapeutics Stem Cells Product Portfolio Table 48. Osiris Therapeutics Recent Development Table 49. NuVasive Company Information Table 50. NuVasive Business Overview Table 51. NuVasive Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. NuVasive Stem Cells Product Portfolio Table 53. NuVasive Recent Development Table 54. Chiesi Pharmaceuticals Company Information Table 55. Chiesi Pharmaceuticals Business Overview Table 56. Chiesi Pharmaceuticals Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Chiesi Pharmaceuticals Stem Cells Product Portfolio Table 58. Chiesi Pharmaceuticals Recent Development Table 59. Medi-post Company Information Table 60. Medi-post Business Overview Table 61. Medi-post Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Medi-post Stem Cells Product Portfolio Table 63. Medi-post Recent Development Table 64. JCR Pharmaceutical Company Information Table 65. JCR Pharmaceutical Business Overview Table 66. JCR Pharmaceutical Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. JCR Pharmaceutical Stem Cells Product Portfolio Table 68. JCR Pharmaceutical Recent Development Table 69. MolMed Company Information Table 70. MolMed Business Overview Table 71. MolMed Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. MolMed Stem Cells Product Portfolio Table 73. MolMed Recent Development Table 74. Pharmicell Company Information Table 75. Pharmicell Business Overview Table 76. Pharmicell Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pharmicell Stem Cells Product Portfolio Table 78. Pharmicell Recent Development Table 79. Anterogen Company Information Table 80. Anterogen Business Overview Table 81. Anterogen Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Anterogen Stem Cells Product Portfolio Table 83. Anterogen Recent Development Table 84. Takeda (TiGenix) Company Information Table 85. Takeda (TiGenix) Business Overview Table 86. Takeda (TiGenix) Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Takeda (TiGenix) Stem Cells Product Portfolio Table 88. Takeda (TiGenix) Recent Development Table 89. CBR Company Information Table 90. CBR Business Overview Table 91. CBR Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. CBR Stem Cells Product Portfolio Table 93. CBR Recent Development Table 94. ViaCord Company Information Table 95. ViaCord Business Overview Table 96. ViaCord Stem Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. ViaCord Stem Cells Product Portfolio Table 98. ViaCord Recent Development Table 99. Esperite Company Information Table 100. Esperite Business Overview Table 101. Esperite Stem Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Esperite Stem Cells Product Portfolio Table 103. Esperite Recent Development Table 104. LifeCell Company Information Table 105. LifeCell Business Overview Table 106. LifeCell Stem Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. LifeCell Stem Cells Product Portfolio Table 108. LifeCell Recent Development Table 109. CCBC Company Information Table 110. CCBC Business Overview Table 111. CCBC Stem Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. CCBC Stem Cells Product Portfolio Table 113. CCBC Recent Development Table 114. VCANBIO Company Information Table 115. VCANBIO Business Overview Table 116. VCANBIO Stem Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. VCANBIO Stem Cells Product Portfolio Table 118. VCANBIO Recent Development Table 119. BOYA LIFE Company Information Table 120. BOYA LIFE Business Overview Table 121. BOYA LIFE Stem Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 122. BOYA LIFE Stem Cells Product Portfolio Table 123. BOYA LIFE Recent Development Table 124. Beike Biotechnology Company Information Table 125. Beike Biotechnology Business Overview Table 126. Beike Biotechnology Stem Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 127. Beike Biotechnology Stem Cells Product Portfolio Table 128. Beike Biotechnology Recent Development Table 129. International Medical Company Information Table 130. International Medical Business Overview Table 131. International Medical Stem Cells Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 132. International Medical Stem Cells Product Portfolio Table 133. International Medical Recent Development Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Stem Cells Product Image Figure 2. Global Stem Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Stem Cells Market Size (2021-2032) & (US$ Million) Figure 4. Global Stem Cells Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Stem Cell Storage Image Figure 8. Stem Cell Pharmaceutical and Treatment Image Figure 9. Global Stem Cells Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Stem Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Stem Cells Sales Value Share by Type (2021-2032) Figure 12. Diseases of the Central Nervous System Image Figure 13. Cardiovascular Disease Image Figure 14. Diabetes Image Figure 15. Cancer Image Figure 16. Genetic Diseases Image Figure 17. Autoimmune Disease Image Figure 18. Bone and Cartilage Repair Image Figure 19. Other Image Figure 20. Global Stem Cells Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Stem Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Stem Cells Sales Value Share by Application (2021-2032) Figure 23. Global Stem Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Stem Cells Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Stem Cells Sales Value (2021-2032) & (US$ Million) Figure 26. North America Stem Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Stem Cells Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Stem Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Stem Cells Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Stem Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Stem Cells Sales Value (2021-2032) & (US$ Million) Figure 32. South America Stem Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Stem Cells Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Stem Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cell Storage
  • Stem Cell Pharmaceutical and Treatment
Applications
  • Diseases of the Central Nervous System
  • Cardiovascular Disease
  • Diabetes
  • Cancer
  • Genetic Diseases
  • Autoimmune Disease
  • Bone and Cartilage Repair
  • Other
Companies covered
  • Osiris Therapeutics
  • NuVasive
  • Chiesi Pharmaceuticals
  • Medi-post
  • JCR Pharmaceutical
  • MolMed
  • Pharmicell
  • Anterogen
  • Takeda (TiGenix)
  • CBR
  • ViaCord
  • Esperite
  • LifeCell
  • CCBC
  • VCANBIO
  • BOYA LIFE
  • Beike Biotechnology
  • International Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Stem Cells Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Stem Cells Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Stem Cells Market Dynamics
  1. 2.1 Stem Cells Industry Trends
  2. 2.2 Stem Cells Industry Drivers
  3. 2.3 Stem Cells Industry Opportunities and Challenges
  4. 2.4 Stem Cells Industry Restraints
3 Stem Cells Market by Company
  1. 3.1 Global Stem Cells Company Revenue Ranking in 2025
  2. 3.2 Global Stem Cells Revenue by Company (2021-2026)
  3. 3.3 Global Stem Cells Company Ranking (2024-2026)
  4. 3.4 Global Stem Cells Company Manufacturing Base and Headquarters
  5. 3.5 Global Stem Cells Company Product Type and Application
  6. 3.6 Global Stem Cells Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Stem Cells Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Stem Cells Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Stem Cells Market by Type
  1. 4.1 Stem Cells Type Introduction
  2. 4.1.1 Stem Cell Storage
  3. 4.1.2 Stem Cell Pharmaceutical and Treatment
  4. 4.2 Global Stem Cells Sales Value by Type
  5. 4.2.1 Global Stem Cells Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Stem Cells Sales Value by Type (2021-2032)
  7. 4.2.3 Global Stem Cells Sales Value Share by Type (2021-2032)
5 Stem Cells Market by Application
  1. 5.1 Stem Cells Application Introduction
  2. 5.1.1 Diseases of the Central Nervous System
  3. 5.1.2 Cardiovascular Disease
  4. 5.1.3 Diabetes
  5. 5.1.4 Cancer
  6. 5.1.5 Genetic Diseases
  7. 5.1.6 Autoimmune Disease
  8. 5.1.7 Bone and Cartilage Repair
  9. 5.1.8 Other
  10. 5.2 Global Stem Cells Sales Value by Application
  11. 5.2.1 Global Stem Cells Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.2.2 Global Stem Cells Sales Value by Application (2021-2032)
  13. 5.2.3 Global Stem Cells Sales Value Share by Application (2021-2032)
6 Stem Cells Regional Value Analysis
  1. 6.1 Global Stem Cells Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Stem Cells Sales Value by Region (2021-2032)
  3. 6.2.1 Global Stem Cells Sales Value by Region: 2021-2026
  4. 6.2.2 Global Stem Cells Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Stem Cells Sales Value (2021-2032)
  7. 6.3.2 North America Stem Cells Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Stem Cells Sales Value (2021-2032)
  10. 6.4.2 Europe Stem Cells Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Stem Cells Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Stem Cells Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Stem Cells Sales Value (2021-2032)
  16. 6.6.2 South America Stem Cells Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Stem Cells Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Stem Cells Sales Value Share by Country, 2025 VS 2032
7 Stem Cells Country-level Value Analysis
  1. 7.1 Global Stem Cells Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Stem Cells Sales Value by Country (2021-2032)
  3. 7.2.1 Global Stem Cells Sales Value by Country (2021-2026)
  4. 7.2.2 Global Stem Cells Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Stem Cells Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Stem Cells Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Stem Cells Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Stem Cells Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Stem Cells Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Stem Cells Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Stem Cells Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Stem Cells Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Stem Cells Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Stem Cells Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Stem Cells Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Stem Cells Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Stem Cells Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Stem Cells Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Stem Cells Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Stem Cells Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Stem Cells Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Stem Cells Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Stem Cells Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Stem Cells Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Stem Cells Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Stem Cells Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Stem Cells Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Stem Cells Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Stem Cells Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Stem Cells Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Stem Cells Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Stem Cells Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Stem Cells Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Stem Cells Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Stem Cells Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Stem Cells Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Stem Cells Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Stem Cells Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Stem Cells Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Stem Cells Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Stem Cells Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Stem Cells Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Stem Cells Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Stem Cells Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Stem Cells Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Stem Cells Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Stem Cells Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Stem Cells Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Stem Cells Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Stem Cells Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Stem Cells Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Stem Cells Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Stem Cells Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Stem Cells Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Stem Cells Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Stem Cells Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Stem Cells Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Stem Cells Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Stem Cells Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Stem Cells Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Stem Cells Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Stem Cells Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Stem Cells Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Stem Cells Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Stem Cells Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Stem Cells Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Stem Cells Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Stem Cells Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Stem Cells Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Stem Cells Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Stem Cells Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Stem Cells Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Stem Cells Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Stem Cells Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Stem Cells Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Stem Cells Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Stem Cells Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Stem Cells Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Stem Cells Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Stem Cells Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Stem Cells Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Stem Cells Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Stem Cells Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Stem Cells Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Stem Cells Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Stem Cells Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Stem Cells Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Stem Cells Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Osiris Therapeutics
  2. 8.1.1 Osiris Therapeutics Company Information
  3. 8.1.2 Osiris Therapeutics Business Overview
  4. 8.1.3 Osiris Therapeutics Stem Cells Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Osiris Therapeutics Stem Cells Product Portfolio
  6. 8.1.5 Osiris Therapeutics Recent Developments
  7. 8.2 NuVasive
  8. 8.2.1 NuVasive Company Information
  9. 8.2.2 NuVasive Business Overview
  10. 8.2.3 NuVasive Stem Cells Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NuVasive Stem Cells Product Portfolio
  12. 8.2.5 NuVasive Recent Developments
  13. 8.3 Chiesi Pharmaceuticals
  14. 8.3.1 Chiesi Pharmaceuticals Company Information
  15. 8.3.2 Chiesi Pharmaceuticals Business Overview
  16. 8.3.3 Chiesi Pharmaceuticals Stem Cells Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chiesi Pharmaceuticals Stem Cells Product Portfolio
  18. 8.3.5 Chiesi Pharmaceuticals Recent Developments
  19. 8.4 Medi-post
  20. 8.4.1 Medi-post Company Information
  21. 8.4.2 Medi-post Business Overview
  22. 8.4.3 Medi-post Stem Cells Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Medi-post Stem Cells Product Portfolio
  24. 8.4.5 Medi-post Recent Developments
  25. 8.5 JCR Pharmaceutical
  26. 8.5.1 JCR Pharmaceutical Company Information
  27. 8.5.2 JCR Pharmaceutical Business Overview
  28. 8.5.3 JCR Pharmaceutical Stem Cells Revenue and Gross Margin (2021-2026)
  29. 8.5.4 JCR Pharmaceutical Stem Cells Product Portfolio
  30. 8.5.5 JCR Pharmaceutical Recent Developments
  31. 8.6 MolMed
  32. 8.6.1 MolMed Company Information
  33. 8.6.2 MolMed Business Overview
  34. 8.6.3 MolMed Stem Cells Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MolMed Stem Cells Product Portfolio
  36. 8.6.5 MolMed Recent Developments
  37. 8.7 Pharmicell
  38. 8.7.1 Pharmicell Company Information
  39. 8.7.2 Pharmicell Business Overview
  40. 8.7.3 Pharmicell Stem Cells Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pharmicell Stem Cells Product Portfolio
  42. 8.7.5 Pharmicell Recent Developments
  43. 8.8 Anterogen
  44. 8.8.1 Anterogen Company Information
  45. 8.8.2 Anterogen Business Overview
  46. 8.8.3 Anterogen Stem Cells Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Anterogen Stem Cells Product Portfolio
  48. 8.8.5 Anterogen Recent Developments
  49. 8.9 Takeda (TiGenix)
  50. 8.9.1 Takeda (TiGenix) Company Information
  51. 8.9.2 Takeda (TiGenix) Business Overview
  52. 8.9.3 Takeda (TiGenix) Stem Cells Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Takeda (TiGenix) Stem Cells Product Portfolio
  54. 8.9.5 Takeda (TiGenix) Recent Developments
  55. 8.10 CBR
  56. 8.10.1 CBR Company Information
  57. 8.10.2 CBR Business Overview
  58. 8.10.3 CBR Stem Cells Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CBR Stem Cells Product Portfolio
  60. 8.10.5 CBR Recent Developments
  61. 8.11 ViaCord
  62. 8.11.1 ViaCord Company Information
  63. 8.11.2 ViaCord Business Overview
  64. 8.11.3 ViaCord Stem Cells Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ViaCord Stem Cells Product Portfolio
  66. 8.11.5 ViaCord Recent Developments
  67. 8.12 Esperite
  68. 8.12.1 Esperite Company Information
  69. 8.12.2 Esperite Business Overview
  70. 8.12.3 Esperite Stem Cells Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Esperite Stem Cells Product Portfolio
  72. 8.12.5 Esperite Recent Developments
  73. 8.13 LifeCell
  74. 8.13.1 LifeCell Company Information
  75. 8.13.2 LifeCell Business Overview
  76. 8.13.3 LifeCell Stem Cells Revenue and Gross Margin (2021-2026)
  77. 8.13.4 LifeCell Stem Cells Product Portfolio
  78. 8.13.5 LifeCell Recent Developments
  79. 8.14 CCBC
  80. 8.14.1 CCBC Company Information
  81. 8.14.2 CCBC Business Overview
  82. 8.14.3 CCBC Stem Cells Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CCBC Stem Cells Product Portfolio
  84. 8.14.5 CCBC Recent Developments
  85. 8.15 VCANBIO
  86. 8.15.1 VCANBIO Company Information
  87. 8.15.2 VCANBIO Business Overview
  88. 8.15.3 VCANBIO Stem Cells Revenue and Gross Margin (2021-2026)
  89. 8.15.4 VCANBIO Stem Cells Product Portfolio
  90. 8.15.5 VCANBIO Recent Developments
  91. 8.16 BOYA LIFE
  92. 8.16.1 BOYA LIFE Company Information
  93. 8.16.2 BOYA LIFE Business Overview
  94. 8.16.3 BOYA LIFE Stem Cells Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BOYA LIFE Stem Cells Product Portfolio
  96. 8.16.5 BOYA LIFE Recent Developments
  97. 8.17 Beike Biotechnology
  98. 8.17.1 Beike Biotechnology Company Information
  99. 8.17.2 Beike Biotechnology Business Overview
  100. 8.17.3 Beike Biotechnology Stem Cells Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Beike Biotechnology Stem Cells Product Portfolio
  102. 8.17.5 Beike Biotechnology Recent Developments
  103. 8.18 International Medical
  104. 8.18.1 International Medical Company Information
  105. 8.18.2 International Medical Business Overview
  106. 8.18.3 International Medical Stem Cells Revenue and Gross Margin (2021-2026)
  107. 8.18.4 International Medical Stem Cells Product Portfolio
  108. 8.18.5 International Medical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst